The oncometabolite d‑2‑hydroxyglutarate induces angiogenic activity through the vascular endothelial growth factor receptor 2 signaling pathway
2019 ◽
2019 ◽
2017 ◽
Vol 32
◽
pp. 285-295
◽
2010 ◽
Vol 102
(1)
◽
pp. 219-225
◽